Bressieux-Degueldre S, Gradoux E, Di Bernardo S, Sekarski N
Pediatric Cardiology Unit, Department of Women-Mother-Child, Lausanne University Hospital, Lausanne, Switzerland.
Department of Women-Mother-Child, Lausanne University Hospital, Lausanne, Switzerland.
Front Pediatr. 2023 Mar 20;11:1137841. doi: 10.3389/fped.2023.1137841. eCollection 2023.
The aim of this national prospective surveillance study was to compare the clinical presentation, laboratory findings, treatment, and coronary artery outcome in patients with incomplete and complete Kawasaki disease (KD).
Between March 2013 and February 2019, children with a diagnosis of complete and incomplete KD were reported by the Swiss Paediatric Surveillance Unit and prospectively enrolled. Clinical data, laboratory values, treatment, and echocardiographic features were collected at diagnosis and 1 year of follow-up. Data were compared between children with complete or incomplete KD.
A total of 351 questionnaires were registered from children with a diagnosis of KD. Of them, 219 (62.4%) children had complete KD, and 132 (37.6%) children had incomplete KD. Children with incomplete KD were younger and had a longer-lasting fever; however, there were no differences in the level of C-reactive protein. All but four children received intravenous immunoglobulin treatment, whereas 14% of children were treated with corticosteroids. Children with incomplete KD were more often treated with corticosteroids than children with incomplete KD ( = 0.01). At diagnosis, 39 (11.1%) patients had only coronary artery dilation and 57 (16.2%) had at least one coronary artery aneurysm. There were no differences in coronary artery involvement between the two groups. At follow-up, 273 of 294 (92.8%) patients had no coronary artery involvement, with no difference between the two groups ( = 0.609). The overall incidence of coronary artery aneurysms at diagnosis was 16.2%. At follow-up, most coronary artery aneurysms had regressed, and coronary artery aneurysms were present in only 5.8% of the patients. Coronary artery aneurysms were slightly more frequent in patients with incomplete KD at follow-up ( = 0.039) but not at diagnosis ( = 0.208).
Although the clinical presentation in children with incomplete and complete KD differs, the absence of coronary artery involvement does not. The use of corticosteroids appears to be preventive against the development of coronary artery aneurysms in these patients. However, the results of this study suggest a lower rate of coronary artery aneurysm regression in patients with incomplete KD. Further studies on a larger scale are needed to assess the risk of non-regression of coronary artery aneurysms in this particular group of patients.
这项全国性前瞻性监测研究的目的是比较不完全性和完全性川崎病(KD)患者的临床表现、实验室检查结果、治疗情况及冠状动脉转归。
2013年3月至2019年2月期间,瑞士儿科监测单位报告并前瞻性纳入了诊断为完全性和不完全性KD的儿童。在诊断时及随访1年时收集临床数据、实验室检查值、治疗情况及超声心动图特征。对完全性或不完全性KD患儿的数据进行比较。
共登记了351份来自诊断为KD患儿的问卷。其中,219例(62.4%)患儿为完全性KD,132例(37.6%)患儿为不完全性KD。不完全性KD患儿年龄较小,发热持续时间较长;然而,C反应蛋白水平无差异。除4例患儿外,所有患儿均接受了静脉注射免疫球蛋白治疗,14%的患儿接受了皮质类固醇治疗。不完全性KD患儿比完全性KD患儿更常接受皮质类固醇治疗(P = 0.01)。诊断时,39例(11.1%)患者仅有冠状动脉扩张,57例(16.2%)至少有一个冠状动脉瘤。两组冠状动脉受累情况无差异。随访时,294例患者中的273例(92.8%)无冠状动脉受累,两组间无差异(P = 0.609)。诊断时冠状动脉瘤的总体发生率为16.2%。随访时,大多数冠状动脉瘤已消退,仅5.8%的患者存在冠状动脉瘤。随访时不完全性KD患者冠状动脉瘤的发生率略高(P = 0.039),但诊断时无差异(P = 0.208)。
尽管不完全性和完全性KD患儿的临床表现不同,但冠状动脉受累情况并无差异。皮质类固醇的使用似乎可预防这些患者冠状动脉瘤的发生。然而,本研究结果提示不完全性KD患者冠状动脉瘤消退率较低。需要进行更大规模的进一步研究,以评估这一特定患者群体中冠状动脉瘤不消退的风险。